Hyuk Joo Jee
Corporate Officer/Principal chez HLB CO., LTD.
Profil
Hyuk Joo Jee is currently working as a Director at Immunomic Therapeutics, Inc. and as a Vice President at HLB Co., Ltd.
He completed his undergraduate degree from Korea University.
Postes actifs de Hyuk Joo Jee
| Sociétés | Poste | Début |
|---|---|---|
| HLB CO., LTD. | Corporate Officer/Principal | - |
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 05/05/2020 |
Formation de Hyuk Joo Jee
| Korea University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HLB CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
